Status:
TERMINATED
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
Lead Sponsor:
University Hospital, Lille
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-85 years
Brief Summary
Inflammatory Bowel Diseases (IBD) including Crohn's disease and ulcerative colitis are multifactorial diseases leading to chronic inflammation of intestinal mucosa. Their etiology is still unknown. Re...
Eligibility Criteria
Inclusion
- Patients who are at least 18 years old
- Has Crohn's disease or ulcerative colitis, diagnosed, confirmed by radiological and / or endoscopic examination within 4 years or "Control" patient not suffering from inflammatory bowel disease (patient with abdominal pain and / or persistent diarrhea, or patient requiring coloscopy for cancer of the digestive tract diagnosis)
- Patients requiring coloscopy as part of their medical follow-up
- Social insured.
Exclusion
- Pregnant women
- Breastfeeding women
- People in emergency
- Persons unable to understand, read and / or sign informed consent
- Patients who recently had an intercurrent episode (eg recent diarrhea ...)
- Persons deprived of their liberty
- Persons protected by a legal protection status
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2019
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT03376230
Start Date
February 1 2010
End Date
January 24 2019
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU, Hôpital Claude Huriez
Lille, France